8-KLeadership Changes

VERTEX PHARMACEUTICALS INC / MA 8-K Report, Executive Changes (Sep 30, 2008)

Filed September 30, 2008For Securities:VRTX

Summary

Vertex Pharmaceuticals Incorporated (VRTX) announced the appointment of Paul Silva as Vice President and Corporate Controller, serving as the Principal Accounting Officer, effective September 29, 2008. Mr. Silva, who joined Vertex in August 2007 as Senior Director of Accounting Operations, brings a background in financial reporting and accounting from previous roles at Iron Mountain Incorporated and Thermo Electron Corporation. This appointment is significant as it fills a key financial leadership position within the company. Investors should note Mr. Silva's experience in financial operations and his progression within Vertex, which suggests a focus on strengthening internal financial controls and reporting capabilities. The timing of this appointment may also be relevant in the context of upcoming financial reporting cycles or strategic initiatives.

Key Highlights

  • 1Paul Silva appointed as Vice President and Corporate Controller (Principal Accounting Officer) on September 29, 2008.
  • 2Mr. Silva has been with Vertex Pharmaceuticals since August 2007, previously serving as Senior Director, Accounting Operations.
  • 3His prior experience includes roles at Iron Mountain Incorporated and Thermo Electron Corporation.
  • 4The appointment addresses a key executive position within the company's financial operations.
  • 5This filing is made under Item 5.02 of Form 8-K, which pertains to the departure or election of directors and officers.
  • 6The report was filed on September 29, 2008, with an event date of September 28, 2008.

Frequently Asked Questions